These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4983812)

  • 1. Intravascular thrombosis and leukocyte destruction in vivo by heterologous antilymphocyte serum.
    Anderson ND; Wood S
    Fed Proc; 1970; 29(1):145-9. PubMed ID: 4983812
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspects in production of antilymphocyte sera.
    Pichlmayr R
    Fed Proc; 1970; 29(1):111-3. PubMed ID: 4983810
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of leukocyte and thrombocyte antibodies in anti-thymocyte globulin (ATG) on the organism].
    Bednarík T; Fiala J; Májský A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(4):622-6. PubMed ID: 4139082
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on heterologous antilymphocyte and antithymocyte sera. IV. Further evidence for a preferential effect on antigen-sensitive cells.
    Barth RF
    J Immunol; 1969 Oct; 103(4):648-54. PubMed ID: 4310736
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on heterologous antilymphocyte and antithymocyte sera. I. Serologic specificity and immunosuppressive activity of rabbit anti-mouse sera on the primary immune response.
    Barth RF; Southworth J; Burger GM
    J Immunol; 1968 Aug; 101(2):282-91. PubMed ID: 4174494
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of antilymphocyte serum against lymphocytes of immunized rats on antibody formation to erythrocytes (guinea pig erythrocytes, human erythrocytes, primary response, secondary response).
    Hrubá A; Paluska E; Krecek M
    Folia Biol (Praha); 1972; 18(5):380-4. PubMed ID: 4636758
    [No Abstract]   [Full Text] [Related]  

  • 7. An immunofluorescent study of the identity of cells reacting with anti-lymphocytic sera.
    Taylor CR
    J Pathol; 1973 Jul; 110(3):221-32. PubMed ID: 4582849
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of heterologous nonthymic antilymphocyte serum on immune responses in the mouse.
    Miller J; Spees EK; Wistar R; Hattler BG
    Surgery; 1972 Jun; 71(6):881-90. PubMed ID: 5030505
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody titre of anti-thymocytic sera against homologous and heterologous organ antigens.
    Bobory J; Leövey A; Petrányi G; Szegedi G
    Haematologia (Budap); 1971; 5(4):413-8. PubMed ID: 5148966
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies in immuno-suppression. Methods to evaluate anti-human lymphocyte sera.
    Balner H; Dersjant H; van Bekkum DW
    Transplant Proc; 1969 Mar; 1(1):629-37. PubMed ID: 5002666
    [No Abstract]   [Full Text] [Related]  

  • 11. [Standardization of antilymphocyte serum].
    Balner H; Traeger J; van Bekkum DW; Carraz M; Fries D; Plan R; Brochier M; Triau R; Charbonnier C; Cotte J; Durix C; Bonneau M; Veyssere C; Prévot J
    Prog Immunobiol Stand; 1970; 4():214-24. PubMed ID: 4991584
    [No Abstract]   [Full Text] [Related]  

  • 12. Human antilymphocytic serum. 1. Production and in-vitro testing.
    McKenzie IF; Morris PJ; Schiff P; de Gabriele G; Sutherland SK
    Med J Aust; 1969 Feb; 1(5):203-7. PubMed ID: 4976009
    [No Abstract]   [Full Text] [Related]  

  • 13. Preliminary studies on antithymocyte globulin.
    Orlowski T; Skopińska E; Kossowska-Paul B; Wasik M; Wojtulewicz-Kurkus J; Klopotowska E; Tupalska B; Filipowicz Z
    Pol Med J; 1971; 10(2):400-7. PubMed ID: 4997629
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on heterologous antilymphocyte and antithymocyte sera. II. Effects on cellular antibody production during the early primary and secondary immune response of mice to sheep erythrocytes.
    Barth RF; Southworth J
    J Immunol; 1968 Dec; 101(6):1283-90. PubMed ID: 5722464
    [No Abstract]   [Full Text] [Related]  

  • 15. [Toxicity and secondary effects of antilymphocyte serums].
    Dormont J; Josso F; Hors J; Jungers P; Bach JF
    J Urol Nephrol (Paris); 1969 Sep; 75(9):589-93. PubMed ID: 4103959
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of subcellular lymphocyte fractions to raise anti- lymphocyte serum.
    Lance EM; Ford P; Ruskziewicz M
    Fed Proc; 1970; 29(1):106-7. PubMed ID: 4904616
    [No Abstract]   [Full Text] [Related]  

  • 17. The reduction of antigenicity of heterologous antilymphocyte serum with acid Taka-protease.
    Amemiya H; Yokoyama T; Torisu M; Putnam CW; Anderson JT; Starzl TE
    Clin Exp Immunol; 1972 May; 11(1):67-81. PubMed ID: 4624986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selected topics on antilymphocyte serum.
    Starzl TE; Penn I; Brettschneider L; Ono K; Kashiwagi N
    Fed Proc; 1970; 29(1):186-90. PubMed ID: 4904623
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the decline in immunosuppressive potency of rabbit anti-mouse thymocyte sera raised by repeated immunization of the same rabbit.
    Ponsford FM; Symes MO
    Folia Biol (Praha); 1971; 17(4):227-35. PubMed ID: 5002373
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological response to sheep red blood cells of mice treated with heterologous antilymphocyte serum in the neonatal period.
    Koltay M; Virág I; Réthy L; Illyés M; Streitmann K
    Rev Fr Etud Clin Biol; 1969 Dec; 14(10):1032-5. PubMed ID: 5377891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.